Article Sidebar
Published:
Mar 7, 2018Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Inhibition of TNF-α and IL-1 by compounds from selected plants for rheumatoid arthritis therapy: <i>In vivo</i> and <i>in silico</i> studies
Abstract
Purpose: To investigate the inhibitory activities of herbal compounds from Curcuma longa, Sophora japonica and Camellia sinensis against tumor necrosis factor alpha (TNF-α) and interleukin-1 (IL-1) using in vivo and in silico tools.
Methods: The extracts of the medicinal herbs (Curcuma longa, Sophora japonica and Camellia sinensis) were evaluated for immune-modulatory activities based using neutrophil oxidative burst assay. The compounds present in the medicinal herbs were screened for their inhibitory effects against TNF-α (PDB ID: 2AZ5) and IL-1 (PDB ID: 2L5X) using Molegro Virtual Docker 6.0 (MVD). The stabilities of the top docking poses were confirmed by Molecular Dynamics (MD) simulation run for 20 nanoseconds (ns).
Results: The herbal compounds exerted strong inhibitory effects against TNF-α (PDB ID: 2AZ5) and IL- 1 (PDB ID: 2L5X), implying their therapeutic potential for use in rheumatoid arthritis (RA). Of the compounds, curcumin diglucoside and curcumin monoglucoside showed the strongest inhibitory effects on monocytes, with inhibitory levels of 82.75 and 81.34 %, respectively, while eugenin had the weakest inhibitory activity (11.12 %). In addition, molecular docking scores were consistent with the in vivo results, and revealed strong inhibitory effects of curcumin diglucoside and curcumin monoglucoside against TNF-α and IL-1.
Conclusion: Herbal compounds present in Curcuma longa, Sophora japonica and Camellia sinensis possess strong inhibitory effects against the pro-inflammatory cytokines TNF-α and IL-1. Thus, these compounds have therapeutic potentials that can be exploited for the treatment of RA.
Keywords: Curcuma longa, Sophora japonica, Camellia sinensis, Rheumatoid arthritis, Cytokines, TNF-α, IL-1, Immuno-modulation, Molecular docking
